Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis

Figure 4 3-year decompensation predictive accuracy of red cell distribution width/platelet ratio and comparison with other non-invasive tools. A: Accuracy of baseline red cell distribution width to platelet ratio in predicting 3-years decompensation; B: Comparison with other non-invasive tools. ALBI: Albumin-Bilirubin; FIB-4: Fibrosis-4; APRI: Aspartate aminotransferase/platelet count ratio index; MELD: Model for End-Stage Liver Disease; RPR: Red cell distribution width to platelet ratio; AUC: Area under the curve.